In the preceding three months, 5 analysts have released ratings for Masimo (NASDAQ:MASI), presenting a wide array of perspectives from bullish to bearish.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

In the assessment of 12-month price targets, analysts unveil insights for Masimo, presenting an average target of $142.4, a high estimate of $166.00, and a low estimate of $117.00. This current average reflects an increase of 26.24% from the previous average price target of $112.80.

Deciphering Analyst Ratings: An In-Depth Analysis

The standing of Masimo among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Masimo's market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on Masimo analyst ratings.

All You Need to Know About Masimo

Financial Milestones: Masimo's Journey

Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.

Revenue Challenges: Masimo's revenue growth over 3 months faced difficulties. As of 31 December, 2023, the company experienced a decline of approximately -11.04%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Masimo's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 6.18%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Masimo's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.57%, the company may face hurdles in achieving optimal financial performance.

Return on Assets (ROA): Masimo's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.12%, the company may face hurdles in generating optimal returns from its assets.

Debt Management: Masimo's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.71, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

Understanding the Relevance of Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

This article was generated by Benzinga's automated content engine and reviewed by an editor.